K Owusu-Edusei1, R Cramer2, H W Chesson2, T L Gift2, J S Leichliter2. 1. Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: kfo0@cdc.gov. 2. Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Abstract
OBJECTIVE: In this study, we examined state-level monthly gonorrhea morbidity and assessed the potential impact of existing expedited partner therapy (EPT) laws in relation to the time that the laws were enacted. STUDY DESIGN: Longitudinal study. METHODS: We obtained state-level monthly gonorrhea morbidity (number of cases/100,000 for males, females and total) from the national surveillance data. We used visual examination (of morbidity trends) and an autoregressive time series model in a panel format with intervention (interrupted time series) analysis to assess the impact of state EPT laws based on the months in which the laws were enacted. RESULTS: For over 84% of the states with EPT laws, the monthly morbidity trends did not show any noticeable decreases on or after the laws were enacted. Although we found statistically significant decreases in gonorrhea morbidity within four of the states with EPT laws (Alaska, Illinois, Minnesota, and Vermont), there were no significant decreases when the decreases in the four states were compared contemporaneously with the decreases in states that do not have the laws. CONCLUSION: We found no impact (decrease in gonorrhea morbidity) attributable exclusively to the EPT law(s). However, these results do not imply that the EPT laws themselves were not effective (or failed to reduce gonorrhea morbidity), because the effectiveness of the EPT law is dependent on necessary intermediate events/outcomes, including sexually transmitted infection service providers' awareness and practice, as well as acceptance by patients and their partners. Published by Elsevier Ltd.
OBJECTIVE: In this study, we examined state-level monthly gonorrhea morbidity and assessed the potential impact of existing expedited partner therapy (EPT) laws in relation to the time that the laws were enacted. STUDY DESIGN: Longitudinal study. METHODS: We obtained state-level monthly gonorrhea morbidity (number of cases/100,000 for males, females and total) from the national surveillance data. We used visual examination (of morbidity trends) and an autoregressive time series model in a panel format with intervention (interrupted time series) analysis to assess the impact of state EPT laws based on the months in which the laws were enacted. RESULTS: For over 84% of the states with EPT laws, the monthly morbidity trends did not show any noticeable decreases on or after the laws were enacted. Although we found statistically significant decreases in gonorrhea morbidity within four of the states with EPT laws (Alaska, Illinois, Minnesota, and Vermont), there were no significant decreases when the decreases in the four states were compared contemporaneously with the decreases in states that do not have the laws. CONCLUSION: We found no impact (decrease in gonorrhea morbidity) attributable exclusively to the EPT law(s). However, these results do not imply that the EPT laws themselves were not effective (or failed to reduce gonorrhea morbidity), because the effectiveness of the EPT law is dependent on necessary intermediate events/outcomes, including sexually transmitted infection service providers' awareness and practice, as well as acceptance by patients and their partners. Published by Elsevier Ltd.
Entities:
Keywords:
Expedited partner therapy; Gonorrhea; Law; Time series analysis
Authors: Matthew R Golden; William L H Whittington; H Hunter Handsfield; James P Hughes; Walter E Stamm; Matthew Hogben; Agnes Clark; Cheryl Malinski; Jennifer R L Helmers; Katherine K Thomas; King K Holmes Journal: N Engl J Med Date: 2005-02-17 Impact factor: 91.245
Authors: Patricia Kissinger; Hamish Mohammed; Gwangi Richardson-Alston; Jami S Leichliter; Stephanie N Taylor; David H Martin; Thomas A Farley Journal: Clin Infect Dis Date: 2005-07-19 Impact factor: 9.079
Authors: Thomas L Gift; Patricia Kissinger; Hamish Mohammed; Jami S Leichliter; Matthew Hogben; Matthew R Golden Journal: Sex Transm Dis Date: 2011-11 Impact factor: 2.830
Authors: Matthew R Golden; Matthew Hogben; H Hunter Handsfield; Janet S St Lawrence; John J Potterat; King K Holmes Journal: Sex Transm Dis Date: 2003-06 Impact factor: 2.830
Authors: Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent Journal: Sex Transm Dis Date: 2013-03 Impact factor: 2.830
Authors: Julia A Schillinger; Patricia Kissinger; Helene Calvet; William L H Whittington; Ray L Ransom; Maya R Sternberg; Stuart M Berman; Charlotte K Kent; David H Martin; M Kim Oh; H Hunter Handsfield; Gail Bolan; Lauri E Markowitz; J Dennis Fortenberry Journal: Sex Transm Dis Date: 2003-01 Impact factor: 2.830
Authors: Matthew R Golden; James P Hughes; Devon D Brewer; King K Holmes; William L H Whittington; Matthew Hogben; Cheryl Malinski; Anne Golding; H Hunter Handsfield Journal: Sex Transm Dis Date: 2007-08 Impact factor: 2.830
Authors: Maria Trent; Hasiya Eihuri Yusuf; Julia Rowell; Jacquelin Toppins; Colin Woods; Steven Huettner; Camille Robinson; Errol L Fields; Arik V Marcell; Ralph DiClemente; Pamela Matson Journal: JMIR Res Protoc Date: 2022-05-25